(Q42465866)

1 November 2017

title

Aliskiren inhibits intracellular angiotensin II levels without affecting (pro)renin receptor signals in human podocytes (English)

1 reference

1 November 2017

7

Moin A Saleem

1 reference

1 November 2017

Mariyo Sakoda

1

1 reference

1 November 2017

Atsuhiro Ichihara

2

1 reference

1 November 2017

Asako Kurauchi-Mito

3

1 reference

1 November 2017

Tatsuya Narita

4

1 reference

1 November 2017

Kenichiro Kinouchi

5

1 reference

1 November 2017

Kanako Murohashi-Bokuda

6

1 reference

1 November 2017

Akira Nishiyama

8

1 reference

1 November 2017

Fumiaki Suzuki

9

1 reference

1 November 2017

Hiroshi Itoh

10

1 reference

1 November 2017

publication date

14 January 2010

1 reference

Journal of Clinical Hypertension

1 November 2017

published in

1 reference

1 November 2017

volume

23

1 reference

1 November 2017

issue

5

1 reference

1 November 2017

page(s)

575-580

1 reference

Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

Aliskiren combined with losartan in type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

Aliskiren-binding increases the half life of renin and prorenin in rat aortic vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

The putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

The (pro)renin receptor and the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

Mechanical strain increases SPARC levels in podocytes: implications for glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

Mechanical stress reduces podocyte proliferation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

Mechanical stretch induces podocyte hypertrophy in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

Activation of a local tissue angiotensin system in podocytes by mechanical strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

Isolation and characterization of native human renin derived from Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

(Pro)renin receptor-mediated activation of mitogen-activated protein kinases in human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

Increased expression of cyclooxygenase-2 in the renal cortex of human prorenin receptor gene-transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

In vitro evidence for an intracellular site of angiotensin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

Clinical pharmacokinetics of candesartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

Pharmacodynamic studies on the angiotensin II type 1 antagonists irbesartan and candesartan based on angiotensin II dose response in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

Aliskiren, a novel orally effective renin inhibitor, exhibits similar pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

RAAS escape: a real clinical entity that may be important in the progression of cardiovascular and renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

Functional renin receptors in renal mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

Functional expression of the renin-angiotensin system in human podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

PLZF and the (pro)renin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

Prorenin Induces Intracellular Signaling in Cardiomyocytes Independently of Angiotensin II

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

Podocyte loss in human hypertensive nephrosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

inferred from DOI database lookup

7 January 2021

based on heuristic

A saturable tissue-angiotensin I converting enzyme (ACE) binding model for the pharmacokinetic analysis of imidapril, a new ACE inhibitor, and its active metabolite in human.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

inferred from DOI database lookup

7 January 2021

based on heuristic

Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.273

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/AJH.2009.273

1 reference

1 November 2017

1 reference